Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways

被引:192
作者
Jass, JR
Biden, KG
Cummings, MC
Simms, LA
Walsh, M
Schoch, E
Metlzer, SJ
Wright, C
Searle, J
Young, J
Leggett, BA
机构
[1] Univ Queensland, Sch Med, Dept Pathol, Herston, Qld 4006, Australia
[2] Royal Brisbane Hosp Fdn, Clin Res Ctr, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia
[3] Royal Brisbane Hosp, Dept Pathol, Brisbane, Qld 4029, Australia
[4] Univ Maryland, Sch Med, Greenbaum Canc Ctr, Baltimore, MD 21201 USA
[5] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA
关键词
microsatellite instability; colorectal adenocarcinoma; serrated polyp; ras mutation; loss of heterozygosity;
D O I
10.1136/jcp.52.6.455
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background-10% of sporadic colorectal cancers are characterised by a low level of microsatellite instability (MSI-L). These are not thought to differ substantially from microsatellite-stable (MSS) cancers, but MSI-L and MSS cancers are distinguished clinicopathologically and in their spectrum of genetic alterations from cancers showing high level microsatellite instability (MSI-H). Aims-To study the distribution of molecular alterations in a series of colorectal cancers stratified by DNA microsatellite instability. Methods-A subset of an unselected series of colorectal cancers was grouped by the finding of DNA MSI at 0 loci (MSS) (n = 51), 1-2 loci (MSI-L) (n = 38) and 3-6 loci (MSI-H) (n = 25). The frequency of K-ras mutation, loss of heterozygosity (LOH) at 5q, 17p and 18q, and patterns of p53 and beta catenin immunohistochemistry was determined in the three groups. Results-MSI-H cancers had a low frequency of K-ras mutation (7%), LOH on chromosomes 5q (0%), 17p (0%) and 18q (12.5%), and a normal pattern of immunostaining for p53 and beta catenin. MSI-L cancers differed from MSS cancers in terms of a higher frequency of K-ras mutation (54% upsilon 27%) (p = 0.01) and lower frequency of 5q LOH (23% upsilon 48%) (p = 0.047). Whereas aberrant p catenin expression and 5q LOH were concordant (both present or both absent) in 57% of MSS cancers, concordance was observed in only 20% of MSI-L cancers (p = 0.01). Conclusions-MSI-L colorectal cancers are distinct from both MSI-H and MSS cancers. This subset combines features of the suppressor and mutator pathways, may be more dependent on K-ras than on the APC gene in the early stages of neoplastic evolution, and a proportion may be related histogenetically to the serrated (hyperplastic) polyp.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 51 条
[1]   Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum [J].
Ajioka, Y ;
Watanabe, H ;
Jass, JR ;
Yokota, Y ;
Kobayashi, M ;
Nishikura, K .
GUT, 1998, 42 (05) :680-684
[2]   C-KI-RAS GENE-MUTATIONS IN DYSPLASIA AND CARCINOMAS COMPLICATING ULCERATIVE-COLITIS [J].
BELL, SM ;
KELLY, SA ;
HOYLE, JA ;
LEWIS, FA ;
TAYLOR, GR ;
THOMPSON, H ;
DIXON, MF ;
QUIRKE, P .
BRITISH JOURNAL OF CANCER, 1991, 64 (01) :174-178
[3]   PROGNOSTIC-SIGNIFICANCE OF K-RAS MUTATIONS IN COLORECTAL-CARCINOMA [J].
BENHATTAR, J ;
LOSI, L ;
CHAUBERT, P ;
GIVEL, JC ;
COSTA, J .
GASTROENTEROLOGY, 1993, 104 (04) :1044-1048
[4]   Expression of bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability [J].
Biden, KG ;
Simms, LA ;
Cummings, M ;
Buttenshaw, R ;
Schoch, E ;
Searle, J ;
Gobe, G ;
Jass, JR ;
Meltzer, SJ ;
Leggett, BA ;
Young, J .
ONCOGENE, 1999, 18 (05) :1245-1249
[5]  
Bocker T, 1997, CANCER RES, V57, P4739
[6]   Mutations of mitotic checkpoint genes in human cancers [J].
Cahill, DP ;
Lengauer, C ;
Yu, J ;
Riggins, GJ ;
Willson, JKV ;
Markowitz, SD ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 392 (6673) :300-303
[7]   Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine [J].
Carethers, JM ;
Hawn, MT ;
Chauhan, DP ;
Luce, MC ;
Marra, G ;
Koi, M ;
Boland, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :199-206
[8]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[9]   C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas [J].
Elnatan, J ;
Goh, HS ;
Smith, DR .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) :491-497
[10]  
FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO